Latest News

Latest News

News from the World Hepatitis Alliance

Medicines Patent Pool looks at hepatitis C

14 Sep 2015

By Keith Alcorn, Infohep.org Greg Perry, Executive Director of the Medicines Patent Pool, told delegates at the World Hepatitis Summit in Glasgow...

World Health Organization calls for ambitious global targets for viral hepatitis control

5 Sep 2015

By Keith Alcorn, Infohep.org The World Health Organization (WHO) is calling for ambitious new global targets for diagnosis, treatment and cure of...

New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit

4 Sep 2015 Bridie Taylor

New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit Global leaders...

World Hepatitis Summit: New data shows relentless rise in hepatitis deaths

2 Sep 2015

New data shows relentless rise in hepatitis deaths: World leaders meet in Scotland to discuss urgent response and move towards elimination of 7th...

Is the elimination of viral hepatitis on the horizon?

28 Jul 2015 Bridie Taylor

Today marks the fifth official World Hepatitis Day where members of the public and the hepatitis community provide a voice for the 4000 lives lost...

Welcoming new members to the World Hepatitis Alliance

17 Jul 2015 Bridie Taylor

Over the past few months we have welcomed a surge of new members to the World Hepatitis Alliance and we are proud to now have 216 member groups in 80...

2 weeks until World Hepatitis Day!

14 Jul 2015 Bridie Taylor

July 28 is now fast approaching and it’s set to be the biggest World Hepatitis Day yet! But we need your support to ensure we reach as many people as...

Calling for greater commitment to the fight against hepatitis at the World Health Assembly

28 May 2015 Bridie Taylor

The 68th session of the World Health Assembly (WHA68) took place in Geneva from 18th-26th May. On 25th May, the World Hepatitis Alliance was invited...

Supporting the launch of guidelines and policies to address viral hepatitis

1 Apr 2015 Bridie Taylor

WHO Injection Safety policy Every year 1.7 million people are infected with hepatitis B through unsafe injection and 315,000 with hepatitis C. Yet up...

Working closely with WHO to develop a global strategy

1 Apr 2015 Bridie Taylor

WHO Strategic and Technical Advisory Committee for hepatitis (STAC-HEP) meeting, Geneva, Switzerland, 19 – 20 February As part of an expert advisory...

Highlighting the importance of patient advocacy at international conferences

31 Mar 2015 Bridie Taylor

24th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Istanbul, Turkey, 12 – 15 March Patient led advocacy is vital in...

How will 2015 be a defining year for the Alliance?

28 Feb 2015 Bridie Taylor

Viral hepatitis is a global killer with alarming mortality rates, yet an increased global commitment to tackling the disease and ground-breaking new...

How does the Alliance really represent hepatitis patients?

28 Feb 2015 Bridie Taylor

The World Hepatitis Alliance prides itself as the true voice of hepatitis patients living all over the world. All our work is overseen by an...

What is the future for hepatitis treatments? And how we can fund hepatitis programmes?

28 Feb 2015 Bridie Taylor

Discussions around hepatitis are dominated by the pioneering new treatments rapidly transforming the landscape and the ensuing heated discussions...

WHA in official relations with WHO: What does this mean for you?

28 Feb 2015 Bridie Taylor

Fundamental to our ability to influence global hepatitis policy and bring about real change in the world of hepatitis is our relationship with the...

Need some inspiration for action? : Initiatives from WHA members

28 Feb 2015 Bridie Taylor

Together our voices are stronger and united we can tackle this global killer! The World Hepatitis Alliance is fortunate enough to be made up of...

Assisting WHO in the development of a global strategy

31 Jan 2015 Bridie Taylor

World Health Organization Member States have urged WHO to develop a comprehensive global strategy on hepatitis. To assist in the development of this...

World Hepatitis Alliance’s ever-growing membership base

31 Jan 2015 Bridie Taylor

Central to the success of the World Hepatitis Alliance are our member groups around the world. To stimulate political interest in and action on...

Joining expert committees to promote harm reduction

31 Jan 2015 Bridie Taylor

Harm reduction policies are proven to save lives. Globally, as many as 67% of People Who Inject Drugs (PWIDs) have hepatitis C and an additional 8.4...

Promoting screening among high risk communities with new multi-lingual tool

31 Jan 2015 Bridie Taylor

In Europe, migrant populations are disproportionally affected by hepatitis B and C. Crucial to reducing the burden is improving screening among these...

Pages

News from infohep

New US guidelines recommend screening of all adults for hepatitis C

12 Dec 2019 aidsmap.com
All adults in the United States should be screened for hepatitis C by healthcare providers as part of routine medical care, updated guidelines from...

Global burden of deaths and liver cancer due to non-alcoholic fatty liver disease growing

11 Dec 2019 Keith Alcorn
Non-alcoholic fatty liver disease is a growing cause of liver cancer and death in some regions of the world, an analysis of global reporting on liver...

Immunotherapy combination improves liver cancer survival

27 Nov 2019 Liz Highleyman
A combination of nivolumab (Opdivo) and ipilimumab (Yervoy), two different types of checkpoint inhibitor immunotherapy, led to higher response rates...

New NASH therapies show promise in mid-stage studies

26 Nov 2019 Liz Highleyman
Phase II study results presented at the AASLD Liver Meeting this month in Boston show that a number of experimental therapies improve markers of...

People with fatty liver disease struggle to lose weight

25 Nov 2019 Liz Highleyman
Losing weight may be especially difficult for people with fatty liver disease due to differences in their metabolism. But nonetheless, some can...

Sustained response to HCV antivirals boosts liver cancer survival

19 Nov 2019 Liz Highleyman
People with liver cancer who achieved a sustained virological response (SVR) to direct-acting antiviral (DAA) therapy for hepatitis C saw a reduction...

Hepatitis B antiviral drugs reduce liver cancer risk

19 Nov 2019 Liz Highleyman
Treating hepatitis B virus (HBV) with nucleoside/nucleotide antiviral drugs was associated with a lower risk of developing hepatocellular carcinoma (...

Hepatitis C incidence is low among Canadian men on PrEP

18 Nov 2019 Liz Highleyman
New cases of hepatitis C virus (HCV) infection among Canadian gay and bisexual men taking pre-exposure prophylaxis (PrEP) were uncommon compared...

Pre- and post-transplant antiviral treatment prevents hepatitis C transmission in all organ recipients, Canadian study finds

14 Nov 2019 Keith Alcorn
Adding a cholesterol-lowering drug to direct-acting antivirals (DAAs) prevented hepatitis C infection in all recipients of organ transplants from...

Coalition of liver associations calls for simplifying hepatitis C care

13 Nov 2019 Liz Highleyman
Leaders of liver disease associations from Europe, the United States, Latin America and Asia issued a global call to action at the AASLD Liver...